Surgical Outcomes of Sequential versus Concomitant Glaucoma Drainage Implant and Boston Keratoprosthesis Type 1

Authors

Varum Patel, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PA
Marlene R. Moster, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PAFollow
Louis J. Kishfy, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PA
Julian Barkan, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PA
Tingting Zhan, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PAFollow
Irving M. Raber, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PA
Brandon D. Ayers, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PA
Michael J. Pro, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PA
Michael Waisbourd, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PAFollow

Document Type

Poster

Publication Date

4-9-2015

Comments

Presented at Sigma XI.

Abstract

BACKGROUND

The Boston Keratoprosthesis Type 1 (KPro) is a surgical device used in patients who have failed traditional corneal transplant treatment or are poor candidates for it.¹ Candidates for KPro often have advanced anterior segment disease that predisposes them to developing glaucoma.² As a result, these patients may require both a KPro, to treat their corneal pathology, and a glaucoma drainage implant (GDI), to treat their glaucoma. To date, there have been no long-term studies comparing the order of GDI placement with KPro surgery and how it affects surgical outcomes.

Recommended Citation

Patel, Varum; Moster, Marlene R.; Kishfy, Louis J.; Barkan, Julian; Zhan, Tingting; Raber, Irving M.; Ayers, Brandon D.; Pro, Michael J.; and Waisbourd, Michael, "Surgical Outcomes of Sequential versus Concomitant Glaucoma Drainage Implant and Boston Keratoprosthesis Type 1" (2015). Wills Eye Hospital Papers. Paper 49.
https://jdc.jefferson.edu/willsfp/49